Thymalin
Also known as: Thymic Factor, Thymus Extract
Popular For
Immune support, thymic function, longevity
Key Facts: Thymalin
- Category
- Bioregulators
- FDA Status
- Not FDA Approved
- Clinical Status
- Approved in Russia - Not FDA approved
- Administration
- Intramuscular injection
- Typical Dose
- 10-20 mg daily for 5-10 days
- Frequency
- Daily during cycles
- Evidence Level
- Human Trials
- Duration
- 10-day cycles, 1-2 times yearly
Mechanism of Action
Thymalin contains peptides that regulate thymic function and T-cell development. It restores age-related immune decline, normalizes thymic hormone levels, and has demonstrated effects on longevity markers in studies.
Research Summary
Russian clinical studies show immune enhancement, reduced infection rates, and potential longevity benefits. Research in elderly demonstrates improved immune parameters. Part of peptide bioregulator approach to aging.
Dosing Information
Typical Dosingⓘ
Community experience
10-20 mg daily for 5-10 days
5-20 mg daily
Daily during cycles
Thymic peptide for immune support. Run in short cycles. Part of Khavinson bioregulator approach.
Research Dosingⓘ
Scientific studies
Doses from clinical practice
Doses from Studies
10 mg daily for 10 days
Courses repeated periodically
Duration
10-day cycles, 1-2 times yearly
Administration
Intramuscular injection
Timing & Administration
Best Time to Take
Morning
Once daily or as directed
Food Recommendation
With or without food
Why This Timing?
Immune peptides align with the body's natural immune rhythm which is more active during the day.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally very well-tolerated
- ●Allergic reactions (rare)
- ●Injection site reactions
- ●Flu-like symptoms (rare)
- ●Excellent safety profile
References
Related Peptides
Peptides commonly compared with Thymalin or used in similar applications.
Epithalon
Clinical TrialsA tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties. Based on research by Professor Vladimir Khavinson.
BioregulatorsCrystagen
PreclinicalA tripeptide bioregulator supporting immune system function. Demonstrates age-associated immunoprotective properties in spleen tissue. Part of the Khavinson synthesized peptide series.
BioregulatorsThymosin Alpha-1
Clinical TrialsA naturally occurring thymic peptide that enhances immune function. Approved in over 35 countries for hepatitis B/C and as an immune adjuvant.
ImmuneVilon
PreclinicalA synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.
BioregulatorsVentfort
PreclinicalA peptide bioregulator targeting vascular tissue and blood vessels. Derived from blood vessel extracts, it supports healthy vascular function and vessel wall integrity. Part of the Khavinson bioregulator family.
BioregulatorsPinealon
PreclinicalA synthetic tripeptide bioregulator targeting brain tissue. Part of Khavinson's peptide research, designed to support cognitive function and neuroprotection.
BioregulatorsLooking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Want updates on Thymalin research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.